6880-04-2

Basic information

• Product Name: 4-Methoxy-3-methylbenzoic acid
• Synonyms: 4-Methoxy-M-toluic acid;4-METHOXY-3-METHYLBENZOIC ACID;ASISCHEM C71547;ASINEX-REAG BAS 12820340;RARECHEM AL BE 0539;4-METHXOY-3-METHYLBENZOIC ACID;4-METHOXY-3-METHYLBENZOIC ACID, 98+%;4-Methoxy-3-methylbenzoic acid3-Methyl-p-anisic acid
• CAS NO: 6880-04-2
• Molecular Formula: C₉H₁₀O₃
• Molecular Weight: 166.17
• EINECS: 1312995-182-4
• Product Categories: Acids and Derivatives;Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts;API intermediates;Acids & Esters;Anisoles, Alkyloxy Compounds & Phenylacetates
• Mol File: 6880-04-2.mol

Chemical Properties

• Melting Point: 177-181 °C(lit.)
• Boiling Point: 285.3°C at 760 mmHg
• Flash Point: 114.2°C
• Appearance: /
• Density: 1.168g/cm³
• Vapor Pressure: 0.00132mmHg at 25°C
• Refractive Index: 1.54
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 4.54±0.10(Predicted)
• CAS DataBase Reference: 4-Methoxy-3-methylbenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methoxy-3-methylbenzoic acid(6880-04-2)
• EPA Substance Registry System: 4-Methoxy-3-methylbenzoic acid(6880-04-2)

Safety Data

• Hazard Codes: Xn
• Statements: 36/37/38-22
• Safety Statements: 26-36/37/39
• WGK Germany: 3
• Hazardous Substances Data: 6880-04-2(Hazardous Substances Data)

Usage

Chemical Properties

Pale yellow or cream powder

InChI:InChI=1/C9H10O3/c1-6-5-7(9(10)11)3-4-8(6)12-2/h3-5H,1-2H3,(H,10,11)

Upstream product

• 14804-31-0 2-methyl-4-bromoanisole 
• 70347-04-5 4-Methoxy-3-methylbenzoesaeure-methylester 
• 499-76-3 4-hydroxy-3-methylbenzoic acid 
• 77-78-1 dimethyl sulfate 
• 10024-90-5 4-methoxy-3-methylacetophenone 
• 7288-04-2 2-methyl-4-propenyl-anisole 
• 64-19-7 acetic acid 
• 124-38-9 carbon dioxide 
• 60736-71-2 3-methyl-4-methoxybenzyl chloride 
• 578-58-5 2-methylmethoxybenzene 
• 201230-82-2 carbon monoxide 
• 7782-50-5 chlorine 
• 32723-67-4 3-methyl-4-anisaldehyde 
• 7664-41-7 ammonia 

Downstream Products

• 59931-48-5 4-methoxy-3-methylbenzoyl chloride 
• 2206-43-1 4-methoxyisophthalic acid 
• 50741-92-9 2-methyl-4-nitroanisole 
• 808750-20-1 3-bromo-4-methoxy-5-methylbenzoic acid 
• 87503-68-2 3-ethenyl-5-methoxy-3,6-dimethyl-1(3H)-isobenzofuranone 
• 82045-51-0 4,5-dihydro-2-(4-methoxy-3-methylphenyl)-4,4-dimethyloxazole 
• 101472-02-0 N-(2-Hydroxy-1,1-dimethyl-ethyl)-4-methoxy-3-methyl-benzamide 
• 328396-66-3 4-methoxy-3-methyl-benzoic acid ethyl ester 
• 70347-04-5 4-Methoxy-3-methylbenzoesaeure-methylester 
• 877759-51-8 (S)-N-(2,3-Dihydro-1H-inden-1-yl)-4-methoxy-3-methylbenzamide 
• 114092-43-2 4-acetoxymethyl-1-(2-hydroxybut-3-en-2-yl)-1-methoxy-2-methylbenzene 
• 114092-42-1 4-hydroxymethyl-5-(2-hydroxybut-3-en-2-yl)-1-methoxy-2-methylbenzene 
• 101212-47-9 methyl 2-<(6'R)-(10-diphenyl-t-butylsiloxy-2,3-dimethyl-1,7-dioxaspiro<5.5>undecan-8-yl)-6',8'-dimethyldecan-2',4',8'-trien-2'-yl>-4-methoxy-5-methylbenzoate 
• 82045-56-5 methyl 2-<(6R)-10-(10-hydroxy-2,3-dimethyl-1,7-dioxaspiro<5.5>undecan-8-yl)-6,8-dimethyldecan-2,4,8-trien-2-yl>-4-methoxy-5-methylbenzoate 

Relevant articles and documents

THERAPEUTIC COMPOUNDS

This invention relates to a novel class of substituted amino-ethoxy benzene derivatives of formula (I) which are inhibitors of serine proteases and to their use in treating aberrant serine protease activity in a mammal, contraception, anti-coagulant methods and methods for treating aberrant cell proliferation, tumours, cancer, angiogenesis, angiogenesis-based retinopathies, autoimmummune disease, inflammation, skin disease, arthritis, rheutmatoid arthritis, asthma, osteoarthritis and multiple sclerosis. (I), Wherein Rm, Rn, Rp, Rq, V, W, X, Y and R8 are as defined in the claims.

De novo asymmetric synthesis of milbemycin β3 via an iterative asymmetric hydration approach

The enantioselective synthesis of the spiroketal/macrolide natural product milbemycin β3 has been achieved in 22 steps and 2.8% overall yield from an achiral dienoate. The spiroketal ring system was installed by three sequential asymmetric hydr

Carboxylation of anisole derivatives with CO and O2 catalyzed by Pd(OAc)2 and molybdovanadophosphates

Anisole and its homologues were carboxylated under the influence of CO and O2 catalyzed by Pd(OAc)2 combined with molybdovanadophosphates (HPMoV) under mild conditions to give the corresponding carboxylic acids in fair to good yields; for instance, anisole underwent the carboxylation under a mixed gas of CO (0.5 atm) and O2 (0.5 atm) in the presence of Pd(OAc)2 (5 mol%) and H5PMo 10V2O40·nH2O (2 mol%) to form an isomeric mixture of anisic acids in good yield.

Towards a total synthesis of the new anticancer agent mensacarcin: Synthesis of the carbocyclic core

A synthesis of the carbocyclic core associated with the new anti-cancer agent mensacarcin (1) is reported. The strategy involves the synthesis of several novel highly substituted aromatic compounds, such as 12 and 23. The lithium derivative of 12 readily

1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds

The present invention relates to substituted 1,4-dihydro-4-oxoquinolines having antiviral activity. The substituents are present at positions 1, 2 and at least one of 5-8 positions of the quinoline ring.

Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists

Novel classes of heterocyclic compounds as adenosine antagonists were developed based on a template approach. Structure-affinity relationships revealed insights for extended knowledge of the receptor-ligand interaction. We replaced the bicyclic heterocycl

Steric Enhancement of Resonance-Evidence from Kinetic Study on some Acetophenones

The kinetics of oxidation of some mono-, di- and tri-substituted acetophenones by alkaline hexacyanoferrate(III) in 50percent (v/v) methanol-water mixture at constant ionic strength and at 20, 30 and 40 deg have been studied spectrophotometrically and the rate constants determined by least-squares analysis.Electron-withdrawing groups in the ring facilitate the oxidation of the acetyl function while electron-releasing groups retard the rate.The rate constant values for the oxidation of 3-substituted-4-alkoxy-acetophenones are computed based on the principle of additivity of group effects.The observed rate constants are significantly lower than the calculated values.This is attributed to the phenomenon of steric enhancement of resonance (SER). 3,5-Disubstituted-4-methoxyacetophenones have higher observed rate constant values than the calculated ones.The steric inhibition of resonance (SIR) operates in these systems.In the case of 3-halogeno-4-methoxyacetophenones, the importance of SER increases with increase in the bulkiness of the 3-substituents.The difference between the calculated and observed multiple substituent constants of 3-substituted-4-methoxyacetophenones also lends support for SER.